04:03 AM EST, 03/06/2025 (MT Newswires) -- QIAGEN NV ( QGEN ) said Thursday that the US Food and Drug Administration has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, marking the company's second FDA clearance of a QIAstat-Dx panel in 2025.

The company said it has now received regulatory clearances for three mini panels for the detection of respiratory and gastrointestinal conditions, which are designed for outpatient use to aid fast treatment decisions.